Paula J McKeown-Longo Selected Research

anastellin

2/2009	Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
11/2008	Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
1/2005	Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paula J McKeown-Longo Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2005
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2005
6	Inflammation (Inflammations) 01/2021 - 01/2015
3	Fibrosis (Cirrhosis) 01/2020 - 01/2015
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2012 - 01/2011
2	Osteosarcoma (Osteogenic Sarcoma) 05/2008 - 03/2006
1	Triple Negative Breast Neoplasms 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Multiple Trauma (Multiple Injuries) 07/2015
1	Keloid 07/2015
1	Pathologic Processes 01/2015
1	Colonic Neoplasms (Colon Cancer) 11/2012
1	Breast Neoplasms (Breast Cancer) 08/2007
1	Infections 01/2005
1	Carcinogenesis 10/2002

Drug/Important Bio-Agent (IBA)

16	Fibronectins (Fibronectin)IBA 01/2022 - 01/2005
8	IntegrinsIBA 01/2021 - 05/2008
5	CytokinesIBA 01/2022 - 10/2002
3	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2011
3	anastellinIBA 02/2009 - 01/2005
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2021
2	LigandsIBA 10/2017 - 10/2017
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 11/2012
2	VitronectinIBA 01/2016 - 03/2006
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	FlagellinIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	AlarminsIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2017
1	OsteopontinIBA 12/2017
1	Interleukin-13IBA 12/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2017
1	src-Family KinasesIBA 10/2017
1	TensinsIBA 10/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2017
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2016
1	CollagenIBA 07/2015
1	human extra domain A fibronectinIBA 07/2015
1	FilaminsIBA 11/2012
1	rho-Associated KinasesIBA 11/2012
1	ElementsIBA 01/2011
1	Peptides (Polypeptides)IBA 02/2009
1	Collagen Type XVIII (Type XVIII Collagen)IBA 11/2008
1	EndostatinsIBA 11/2008
1	Transcription Factors (Transcription Factor)IBA 08/2007
1	Factor VIII (Coagulation Factor VIII)IBA 08/2007
1	Cadherins (E-Cadherin)IBA 08/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2006
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	ThymidineIBA 01/2005
1	Cyclin AIBA 01/2005
1	Cyclin D1IBA 01/2005
1	Estrogen ReceptorsIBA 01/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 11/2008
1	Drug Therapy (Chemotherapy) 01/2016